Ms Moray Carla Wilson, LICSW in Amesbury, MA - Social Worker

Ms Moray Carla Wilson, LICSW is a Social Worker - Clinical based in Amesbury, Massachusetts. Ms Moray Carla Wilson is licensed to practice in Massachusetts (license number 117448) and her current practice location is 12 Market Sq, Amesbury, Massachusetts. She can be reached at her office (for appointments etc.) via phone at (978) 903-2030.

NPI number for Ms Moray Carla Wilson is 1699279851 and her current mailing address is 12 Market Sq Apt 2, Amesbury, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1699279851.

Contact Information

	Ms Moray Carla Wilson, LICSW
	12 Market Sq, Amesbury, MA 01913-2442
	(978) 903-2030
	Not Available

Healthcare Provider's Profile

Full Name	Ms Moray Carla Wilson
Gender	Female
Speciality	Social Worker - Clinical
Location	12 Market Sq, Amesbury, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1699279851
Provider Enumeration Date: 03/22/2018
Last Update Date: 07/18/2023

Medical Identifiers

Medical identifiers for Ms Moray Carla Wilson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1699279851	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	117448 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Moray Carla Wilson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Moray Carla Wilson, LICSW 12 Market Sq Apt 2, Amesbury, MA 01913-2442 Ph: (617) 721-1597	Ms Moray Carla Wilson, LICSW 12 Market Sq, Amesbury, MA 01913-2442 Ph: (978) 903-2030

News Archive

Atrix Signs Feasibility Agreement for Development of Two New Compounds

Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.

USPTO rejects patent claims asserted against Precision BioSciences

Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued Final Decisions and Right of Appeal Notices in the reexamination proceedings for U.S. Pat. Nos. 6,833252, 7,214,536, 6,610,545 and 7,309,605 that are owned by the Institut Pasteur and the Universite Pierre et Marie Curie, and licensed to Cellectis, SA (ALCLS).

New drug for Type 2 diabetes results in less hypoglycaemia, less weight gain and perhaps less cardiovascular risk for patients

A new drug could offer significant advantages over existing treatments for Type 2 diabetes patients who don't respond to metformin, the most commonly prescribed initial drug treatment for the disease. The new drug, linagliptin, results in significantly less weight gain than the most common second-line treatments currently used, and may even carry a smaller risk of cardiovascular events such as heart attack and stroke, according to an Article published Online First in The Lancet.

Women with HER2+ breast tumors who receive combination therapy unlikely to have cancer recur

In a new study, women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted therapy following surgery or radiation therapy were very unlikely to have the cancer recur within a few years of treatment, investigators at Dana-Farber Cancer Institute and other research centers will report at the 2013 San Antonio Breast Cancer Symposium.

Addus HomeCare's net service revenues increase 3.3% to $84.3 million in Q3 2015

Addus HomeCare Corporation, a comprehensive provider of home and community-based services that are primarily personal in nature, provided in the home and focused on the dual eligible population, today announced its financial results for the third quarter and nine months ended September 30, 2015.

Social Worker in Amesbury, MA

Adrienne Luisi-gayton, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5 Market Square, Suite B5, Amesbury, MA 01913 Phone: 978-388-7032 Fax: 978-388-6080
Ms. Michelle M Nickerson, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12 Market Square, Suite 2, Amesbury, MA 01913 Phone: 857-285-8265
Kathleen Lovell, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 5 Market Sq, Suite B5, Amesbury, MA 01913 Phone: 978-388-7032 Fax: 978-388-6080
Mr. Eric Omar King, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 25 Belmont St, Amesbury, MA 01913 Phone: 978-500-5937
Carol Bernstein, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 5 Market Sq, Suite B, Amesbury, MA 01913 Phone: 978-388-7032 Fax: 978-388-6080
Ms. Patricia Gale Wallerstein, MSW LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 Main Street, Suite 11, Amesbury, MA 01913 Phone: 978-388-5311 Fax: 978-388-5571
John M Longo, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 110 Haverhill Rd, Amesbury, MA 01913 Phone: 978-388-8054 Fax: 978-388-8033

Ms Moray Carla Wilson, LICSW - Clinical Social Worker in Amesbury, MA